Henry Schein, Inc. (LON:0L3C)
London flag London · Delayed Price · Currency is GBP · Price in USD
76.18
-1.38 (-1.77%)
Dec 24, 2025, 2:30 PM BST

Henry Schein Revenue

Henry Schein had revenue of $3.34B USD in the quarter ending September 27, 2025, with 5.20% growth. This brings the company's revenue in the last twelve months to $12.94B, up 3.51% year-over-year. In the year 2024, Henry Schein had annual revenue of $12.67B with 2.71% growth.

Revenue (ttm)
$12.94B
Revenue Growth
+3.51%
P/S Ratio
0.69
Revenue / Employee
$517.52K
Employees
25,000
Market Cap
6.65B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 28, 202412.67B334.00M2.71%
Dec 30, 202312.34B-308.00M-2.44%
Dec 31, 202212.65B246.00M1.98%
Dec 25, 202112.40B2.28B22.55%
Dec 26, 202010.12B133.20M1.33%
Dec 28, 20199.99B568.20M6.03%
Dec 29, 20189.42B534.17M6.01%
Mar 31, 20188.88B--
Dec 30, 20178.88B-2.69B-23.23%
Dec 31, 201611.57B941.95M8.86%
Dec 26, 201510.63B258.33M2.49%
Dec 27, 201410.37B810.74M8.48%
Dec 28, 20139.56B620.68M6.94%
Dec 29, 20128.94B409.73M4.80%
Dec 31, 20118.53B1.00B13.33%
Dec 25, 20107.53B988.45M15.12%
Dec 26, 20096.54B157.92M2.48%
Dec 27, 20086.38B490.53M8.33%
Dec 29, 20075.89B853.95M16.96%
Dec 30, 20065.04B509.92M11.27%
Dec 31, 20054.53B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
AstraZeneca43.24B
GSK plc32.17B
Haleon11.02B
Smith & Nephew4.33B
Hikma Pharmaceuticals2.35B
Convatec Group1.72B
Genus672.80M
HUTCHMED (China)439.54M
Revenue Rankings